HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Shingo Harita Selected Research
Shingo Harita Research Topics
Disease
25
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 07/2004
12
Lung Neoplasms (Lung Cancer)
02/2021 - 01/2005
6
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2016 - 05/2002
5
Neoplasms (Cancer)
01/2021 - 01/2010
2
Diarrhea
12/2018 - 01/2016
2
Disease Progression
11/2016 - 01/2010
2
Disseminated Intravascular Coagulation
12/2015 - 11/2012
2
Stomach Neoplasms (Stomach Cancer)
12/2015 - 11/2012
2
Carcinoma (Carcinomatosis)
12/2015 - 12/2002
2
Neoplasm Metastasis (Metastasis)
11/2012 - 02/2005
2
Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2010 - 09/2005
2
Interstitial Lung Diseases (Interstitial Lung Disease)
02/2010 - 09/2005
2
Neutropenia
08/2006 - 07/2004
1
Dysbiosis
01/2021
1
Hypokalemia
12/2018
1
Esophagitis
01/2017
1
Gastritis
01/2017
1
Exanthema (Rash)
01/2016
1
Mucositis
01/2016
1
Thrombocytopenia (Thrombopenia)
08/2006
1
Febrile Neutropenia
08/2006
1
Hamman-Rich Syndrome (Hamman Rich Syndrome)
09/2005
1
Thoracic Diseases
02/2005
1
Brain Diseases (Brain Disorder)
02/2005
1
Brain Neoplasms (Brain Tumor)
02/2005
1
Pleural Effusion (Pleural Effusions)
12/2002
1
Tuberculosis (Tuberculoses)
12/2002
1
Pneumonia (Pneumonitis)
12/2002
1
Heart Failure
12/2002
Drug/Important Bio-Agent (IBA)
8
Cisplatin (Platino)
FDA Link
Generic
10/2016 - 03/2006
7
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 01/2010
6
Gefitinib (Iressa)
FDA Link
01/2016 - 01/2005
5
Immune Checkpoint Inhibitors
IBA
11/2021 - 01/2021
5
Tyrosine Kinase Inhibitors
IBA
12/2018 - 01/2010
5
Docetaxel (Taxotere)
FDA Link
11/2012 - 07/2004
4
Topotecan (Hycamtin)
FDA Link
Generic
10/2016 - 06/2006
3
Afatinib
IBA
12/2018 - 01/2016
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2016 - 01/2010
3
amrubicin
IBA
10/2011 - 05/2005
3
Irinotecan (Camptosar)
FDA Link
Generic
06/2007 - 07/2004
2
Anti-Bacterial Agents (Antibiotics)
IBA
11/2021 - 01/2021
2
Anaplastic Lymphoma Kinase
IBA
01/2019 - 11/2016
2
Platinum
IBA
01/2017 - 07/2004
2
Dacarbazine (DIC)
FDA Link
Generic
12/2015 - 11/2012
2
Gemcitabine
FDA Link
06/2007 - 03/2006
2
Etoposide (VP 16)
FDA Link
Generic
06/2007 - 05/2002
1
B7-H1 Antigen
IBA
02/2021
1
Programmed Cell Death 1 Receptor
IBA
02/2021
1
Pharmaceutical Preparations
IBA
01/2019
1
Cytotoxins (Cytolysins)
IBA
12/2018
1
Creatinine
IBA
12/2018
1
Alginates
IBA
01/2017
1
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
11/2016
1
alectinib
IBA
11/2016
1
Crizotinib
IBA
11/2016
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
11/2016
1
Therapeutic Uses
IBA
01/2016
1
Monoclonal Antibodies
IBA
12/2015
1
Trastuzumab (Herceptin)
FDA Link
12/2015
1
human ERBB2 protein
IBA
12/2015
1
Fluorouracil (Carac)
FDA Link
Generic
01/2011
1
Vindesine (Vindesin)
IBA
07/2010
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
07/2010
1
Biomarkers (Surrogate Marker)
IBA
01/2010
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
06/2007
1
Doxorubicin (Adriamycin)
FDA Link
Generic
06/2007
1
Vinorelbine (Navelbine)
FDA Link
Generic
02/2005
1
2- cyclohexylidenhydrazo- 4- phenyl- thiazole
IBA
07/2004
1
Collagen Type III (Type III Collagen)
IBA
12/2002
1
Interleukin-2 Receptors (IL 2 Receptor)
IBA
12/2002
1
Carboplatin (JM8)
FDA Link
Generic
05/2002
Therapy/Procedure
11
Drug Therapy (Chemotherapy)
12/2018 - 02/2005
9
Therapeutics
02/2021 - 02/2005
8
Radiotherapy
08/2021 - 02/2005
5
Combination Drug Therapy (Combination Chemotherapy)
11/2012 - 05/2002
2
Chemoradiotherapy
01/2017 - 02/2005